Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease — Stella

Recruiting

Back to Thyroid-Associated Ophthalmopathy trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Norway

Department of Ophthalmology Haukeland University Hospital, Bergen, Hordaland

Key details

Phase

Safety & dosing

Sponsor

Haukeland University Hospital

Enrollment target

~60 participants

Started

January 2023

Primary completion

January 2028

Age range

18 Years – 80 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov